Eur J Pediatr Surg 2020; 30(06): 517-523
DOI: 10.1055/s-0039-3400285
Original Article

Intramural Injection of Botulinum Toxin A in Surgical Treatment of a Long Gap Esophageal Atresia—Rat Model

Ashton Hideki Pike
1   Department of Surgery, University of Vermont Larner College of Medicine, Burlington, Vermont, United States
,
Peter Zvara
2   Department of Clinical Research, University of Southern Denmark, Odense, Syddanmark, Denmark
,
Marijana Rincic Antulov
3   Department of Surgery, Sygehus Sønderjylland, Aabenraa, Denmark
,
Henrik Daa Schrøder
4   Department of Pathology, Odense University Hospital, Odense, Denmark
,
Eva Kildall Hejboel
4   Department of Pathology, Odense University Hospital, Odense, Denmark
,
Lars Rasmussen
5   Department of Surgery, Odense University Hospital, Odense, Denmark
,
Niels Qvist
5   Department of Surgery, Odense University Hospital, Odense, Denmark
,
Mark Bremholm Ellebæk
5   Department of Surgery, Odense University Hospital, Odense, Denmark
› Author Affiliations

Abstract

Introduction Anastomosis with minimal tension is desirable in long-gap esophageal atresia. Prior studies in piglets showed that intraesophageal injection of botulinum toxin type A (BTX-A) results in significant esophageal elongation. Our aim was to determine the BTX-A dose, number of injections, and time necessary to elicit maximal response.

Materials and Methods Adult male Wistar rats (n = 48) were randomly assorted into five groups. Four treatment groups received 2 or 4 U/kg of BTX-A, delivered using two or four injections, and a control group received 0.9% NaCl. Esophagus was removed 6 or 24-hours postinjection and tested ex vivo using a stretch tension device. Subsequently, an optimal dose and time following injection was used to study the effects of BTX-A on anastomotic healing in vivo. Rats (n = 12) received an intraesophageal injection of BTX-A or 0.9% NaCl, followed by resection of 0.5 cm of esophagus and end-to-end anastomosis. Rats were observed for 9 days, and esophagus was removed for gross and histological evaluation.

Results The largest effect on elongation was recorded in the BTX-A (2 U/kg) 24 hour, four injection group. In the anastomosis study, stricture formation was observed in all animals in the control group. Absence of esophageal stricture was found in three out of four animals in the treatment group macroscopically and histologically.

Conclusion We found that BTX-A exerts a positive effect on stretch characteristics of esophageal tissue in rats at 2 U/kg via four-injection delivery and 24-hour waiting period. This study suggests that BTX-A might improve anastomotic healing.



Publication History

Received: 07 June 2019

Accepted: 04 October 2019

Article published online:
13 December 2019

© 2020. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Ron O, De Coppi P, Pierro A. The surgical approach to esophageal atresia repair and the management of long-gap atresia: results of a survey. Semin Pediatr Surg 2009; 18 (01) 44-49
  • 2 Bagolan P, Iacobelli Bd Bd, De Angelis P. et al. Long gap esophageal atresia and esophageal replacement: moving toward a separation?. J Pediatr Surg 2004; 39 (07) 1084-1090
  • 3 Foker JE, Linden BC, Boyle Jr EM, Marquardt C. Development of a true primary repair for the full spectrum of esophageal atresia. Ann Surg 1997; 226 (04) 533-541
  • 4 Foker JE, Kendall TC, Catton K, Khan KM. A flexible approach to achieve a true primary repair for all infants with esophageal atresia. Semin Pediatr Surg 2005; 14 (01) 8-15
  • 5 Tovar JA, Fragoso AC. Current controversies in the surgical treatment of esophageal atresia. Scand J Surg 2011; 100 (04) 273-278
  • 6 Tannuri U, Maksoud-Filho JG, Tannuri AC, Andrade W, Maksoud JG. Which is better for esophageal substitution in children, esophagocoloplasty or gastric transposition? A 27-year experience of a single center. J Pediatr Surg 2007; 42 (03) 500-504
  • 7 Lacy BE, Weiser K, Kennedy A. Botulinum toxin and gastrointestinal tract disorders: panacea, placebo, or pathway to the future?. Gastroenterol Hepatol (NY) 2008; 4 (04) 283-295
  • 8 Larsen HF, Jensen TS, Rasmussen L, Ellebæk M, Qvist N. Intramural injection with botulinum toxin significantly elongates the pig esophagus. J Pediatr Surg 2013; 48 (10) 2032-2035
  • 9 Ellebæk MB, Qvist N, Schrøder HD, Rasmussen L. Intramural injection with botulinum toxin type A in piglet esophagus. The influencer on maximum load and elongation: a dose response study. Eur J Pediatr Surg 2016; 26 (03) 282-286
  • 10 Ellebæk M, Qvist N, Rasmussen L. Secondary anastomosis after preoperative botulinum type A toxin injection in a case with long gap oesophageal atresia. Eur J Pediatr Surg 2013; 23 (04) 325-326
  • 11 Mach-Detiefsen B. P-56. Botox injection for primary oesophageal anastomosis in two pre terms with oesophageal atresia type IIIA and type II. Paper presented at: 12th European Congress of Pediatric Surgery; June 15–18, 2011; Barcelona
  • 12 Dibbern CB, Rose M, Ellebæk MB, Qvist N. The effect of intramural botulinum toxin injections on the elongation of the piglet oesophagus is time dependent. Eur J Pediatr Surg 2017; 27 (01) 56-60
  • 13 Shaari CM, Sanders I. Quantifying how location and dose of botulinum toxin injections affect muscle paralysis. Muscle Nerve 1993; 16 (09) 964-969
  • 14 Usui Y, Ono S. Impact of botulinum toxin A injection on esophageal anastomosis in a rabbit model. Pediatr Surg Int 2016; 32 (09) 881-886
  • 15 Wörl J, Mayer B, Neuhuber WL. Nitrergic innervation of the rat esophagus: focus on motor endplates. J Auton Nerv Syst 1994; 49 (03) 227-233